Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1055 participants
OBSERVATIONAL
2016-02-26
2020-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Healthcare Workers Knowledge Regarding Their Vaccination Status at Melun Hospital
NCT06650722
Environmental Health Effects on Your Physiology
NCT03986814
Advancing Tools for Human Early Lifecourse Exposome Research and Translation- Adolescence Follow-up of the HELIX Subcohort
NCT05158010
The PEARL-AGE Study. Multigenerational Gut Bacteria Transmission and Its Stability in Families.
NCT05346016
Health Literacy in the General Population in Belgium
NCT03561636
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness and ability of parents to consent for 2 year follow-up involving frequent electronic questionnaires and freezing of faecal samples at home
* Infant born on gestational weeks 37-42 without known congenital defects
Exclusion Criteria
* Severe birth defect
* Parents fail to activate the online questionnaires
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Business Finland
OTHER
Valio Ltd
INDUSTRY
Finnish Red Cross Blood Service
OTHER
DuPont Nutrition and Health
INDUSTRY
Oriola Corporation
UNKNOWN
Pikkujätti Medical Centre for Children and Youth
UNKNOWN
University of Helsinki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne Salonen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Willem M de Vos, Professor
Role: STUDY_DIRECTOR
University of Helsinki
Anne Salonen, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Helsinki
Kaija-Leena Kolho, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Helsinki
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Microbiome Research Program, Faculty of Medicine, University of Helsinki
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Korpela K, Kallio S, Salonen A, Hero M, Kukkonen AK, Miettinen PJ, Savilahti E, Kohva E, Kariola L, Suutela M, Tarkkanen A, de Vos WM, Raivio T, Kuitunen M. Gut microbiota develop towards an adult profile in a sex-specific manner during puberty. Sci Rep. 2021 Dec 2;11(1):23297. doi: 10.1038/s41598-021-02375-z.
Korpela K, Dikareva E, Hanski E, Kolho KL, de Vos WM, Salonen A. Cohort profile: Finnish Health and Early Life Microbiota (HELMi) longitudinal birth cohort. BMJ Open. 2019 Jun 27;9(6):e028500. doi: 10.1136/bmjopen-2018-028500.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
263/13/03/03/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.